NUK - logo
E-viri
Recenzirano Odprti dostop
  • Retinal biomarkers and phar...
    Romano, Giovanni Luca; Platania, Chiara Bianca Maria; Leggio, Gian Marco; Torrisi, Sebastiano Alfio; Giunta, Salvatore; Salomone, Salvatore; Purrello, Michele; Ragusa, Marco; Barbagallo, Cristina; Giblin, Frank J; Mastrogiacomo, Rosa; Managò, Francesca; Cammalleri, Maurizio; Papaleo, Francesco; Drago, Filippo; Bucolo, Claudio

    Scientific reports, 03/2020, Letnik: 10, Številka: 1
    Journal Article

    Deletion of dystrobrevin binding protein 1 has been linked to Hermansky-Pudlak syndrome type 7 (HPS-7), a rare disease characterized by oculocutaneous albinism and retinal dysfunction. We studied dysbindin-1 null mutant mice (Dys ) to shed light on retinal neurodevelopment defects in HPS-7. We analyzed the expression of a focused set of miRNAs in retina of wild type (WT), Dys and Dys mice. We also investigated the retinal function of these mice through electroretinography (ERG). We found that miR-101-3p, miR-137, miR-186-5p, miR-326, miR-382-5p and miR-876-5p were up-regulated in Dys mice retina. Dys mice showed significant increased b-wave in ERG, compared to WT mice. Bioinformatic analysis highlighted that dysregulated miRNAs target synaptic plasticity and dopaminergic signaling pathways, affecting retinal functions of Dys mice. Overall, the data indicate potential mechanisms in retinal neurodevelopment of Dys mice, which may have translational significance in HSP-7 patients, both in terms of diagnostic/prognostic biomarkers and novel pharmacological targets.